The global Branded Generics market size was valued at USD 321 million in 2023 and is forecast to a readjusted size of USD 544.8 million by 2030 with a CAGR of 7.8% during review period.
This report mainly focuses on branded generics market. Branded generics are generic drugs that have been given a proprietary market name. They may be marketed similarly to how branded drugs are. Branded generic drugs attach proprietary names to generic drug molecules.听
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report includes an overview of the development of the Branded Generics industry chain, the market status of Oncology (Oral, Parenteral), Cardiovascular Diseases (Oral, Parenteral), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Branded Generics.
Regionally, the report analyzes the Branded Generics markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Branded Generics market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Branded Generics market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Branded Generics industry.
The report involves analyzing the market at a macro level:
麻豆原创 Sizing and Segmentation: Report collect data on the overall market size, including the sales quantity (K MT), revenue generated, and market share of different by Type (e.g., Oral, Parenteral).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Branded Generics market.
Regional Analysis: The report involves examining the Branded Generics market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
麻豆原创 Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Branded Generics market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Branded Generics:
Company Analysis: Report covers individual Branded Generics manufacturers, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Branded Generics This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Oncology, Cardiovascular Diseases).
Technology Analysis: Report covers specific technologies relevant to Branded Generics. It assesses the current state, advancements, and potential future developments in Branded Generics areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Branded Generics market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
麻豆原创 Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
麻豆原创 Segmentation
Branded Generics market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
麻豆原创 segment by Type
Oral
Parenteral
Topical
Other
麻豆原创 segment by Application
Oncology
Cardiovascular Diseases
Diabetes
Neurology
Gastrointestinal Diseases
Others
Major players covered
Mylan NV
Novartis AG
Eva Pharmaceutical Industries
Pfizer
Sun Pharmaceutical Industries
Aspen Pharmacare Holding
Abbott Laboratories
Bausch Health
麻豆原创 segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Branded Generics product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Branded Generics, with price, sales, revenue and global market share of Branded Generics from 2019 to 2024.
Chapter 3, the Branded Generics competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Branded Generics breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2019 to 2030.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2019 to 2030.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2023.and Branded Generics market forecast, by regions, type and application, with sales and revenue, from 2025 to 2030.
Chapter 12, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Branded Generics.
Chapter 14 and 15, to describe Branded Generics sales channel, distributors, customers, research findings and conclusion.
Please Note - This is an on demand report and will be delivered in 2 business days (48 Hours) post payment.
1 麻豆原创 Overview
1.1 Product Overview and Scope of Branded Generics
1.2 麻豆原创 Estimation Caveats and Base Year
1.3 麻豆原创 Analysis by Type
1.3.1 Overview: Global Branded Generics Consumption Value by Type: 2019 Versus 2023 Versus 2030
1.3.2 Oral
1.3.3 Parenteral
1.3.4 Topical
1.3.5 Other
1.4 麻豆原创 Analysis by Application
1.4.1 Overview: Global Branded Generics Consumption Value by Application: 2019 Versus 2023 Versus 2030
1.4.2 Oncology
1.4.3 Cardiovascular Diseases
1.4.4 Diabetes
1.4.5 Neurology
1.4.6 Gastrointestinal Diseases
1.4.7 Others
1.5 Global Branded Generics 麻豆原创 Size & Forecast
1.5.1 Global Branded Generics Consumption Value (2019 & 2023 & 2030)
1.5.2 Global Branded Generics Sales Quantity (2019-2030)
1.5.3 Global Branded Generics Average Price (2019-2030)
2 Manufacturers Profiles
2.1 Mylan NV
2.1.1 Mylan NV Details
2.1.2 Mylan NV Major Business
2.1.3 Mylan NV Branded Generics Product and Services
2.1.4 Mylan NV Branded Generics Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.1.5 Mylan NV Recent Developments/Updates
2.2 Novartis AG
2.2.1 Novartis AG Details
2.2.2 Novartis AG Major Business
2.2.3 Novartis AG Branded Generics Product and Services
2.2.4 Novartis AG Branded Generics Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.2.5 Novartis AG Recent Developments/Updates
2.3 Eva Pharmaceutical Industries
2.3.1 Eva Pharmaceutical Industries Details
2.3.2 Eva Pharmaceutical Industries Major Business
2.3.3 Eva Pharmaceutical Industries Branded Generics Product and Services
2.3.4 Eva Pharmaceutical Industries Branded Generics Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.3.5 Eva Pharmaceutical Industries Recent Developments/Updates
2.4 Pfizer
2.4.1 Pfizer Details
2.4.2 Pfizer Major Business
2.4.3 Pfizer Branded Generics Product and Services
2.4.4 Pfizer Branded Generics Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.4.5 Pfizer Recent Developments/Updates
2.5 Sun Pharmaceutical Industries
2.5.1 Sun Pharmaceutical Industries Details
2.5.2 Sun Pharmaceutical Industries Major Business
2.5.3 Sun Pharmaceutical Industries Branded Generics Product and Services
2.5.4 Sun Pharmaceutical Industries Branded Generics Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.5.5 Sun Pharmaceutical Industries Recent Developments/Updates
2.6 Aspen Pharmacare Holding
2.6.1 Aspen Pharmacare Holding Details
2.6.2 Aspen Pharmacare Holding Major Business
2.6.3 Aspen Pharmacare Holding Branded Generics Product and Services
2.6.4 Aspen Pharmacare Holding Branded Generics Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.6.5 Aspen Pharmacare Holding Recent Developments/Updates
2.7 Abbott Laboratories
2.7.1 Abbott Laboratories Details
2.7.2 Abbott Laboratories Major Business
2.7.3 Abbott Laboratories Branded Generics Product and Services
2.7.4 Abbott Laboratories Branded Generics Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.7.5 Abbott Laboratories Recent Developments/Updates
2.8 Bausch Health
2.8.1 Bausch Health Details
2.8.2 Bausch Health Major Business
2.8.3 Bausch Health Branded Generics Product and Services
2.8.4 Bausch Health Branded Generics Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.8.5 Bausch Health Recent Developments/Updates
3 Competitive Environment: Branded Generics by Manufacturer
3.1 Global Branded Generics Sales Quantity by Manufacturer (2019-2024)
3.2 Global Branded Generics Revenue by Manufacturer (2019-2024)
3.3 Global Branded Generics Average Price by Manufacturer (2019-2024)
3.4 麻豆原创 Share Analysis (2023)
3.4.1 Producer Shipments of Branded Generics by Manufacturer Revenue ($MM) and 麻豆原创 Share (%): 2023
3.4.2 Top 3 Branded Generics Manufacturer 麻豆原创 Share in 2023
3.4.2 Top 6 Branded Generics Manufacturer 麻豆原创 Share in 2023
3.5 Branded Generics 麻豆原创: Overall Company Footprint Analysis
3.5.1 Branded Generics 麻豆原创: Region Footprint
3.5.2 Branded Generics 麻豆原创: Company Product Type Footprint
3.5.3 Branded Generics 麻豆原创: Company Product Application Footprint
3.6 New 麻豆原创 Entrants and Barriers to 麻豆原创 Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
4.1 Global Branded Generics 麻豆原创 Size by Region
4.1.1 Global Branded Generics Sales Quantity by Region (2019-2030)
4.1.2 Global Branded Generics Consumption Value by Region (2019-2030)
4.1.3 Global Branded Generics Average Price by Region (2019-2030)
4.2 North America Branded Generics Consumption Value (2019-2030)
4.3 Europe Branded Generics Consumption Value (2019-2030)
4.4 Asia-Pacific Branded Generics Consumption Value (2019-2030)
4.5 South America Branded Generics Consumption Value (2019-2030)
4.6 Middle East and Africa Branded Generics Consumption Value (2019-2030)
5 麻豆原创 Segment by Type
5.1 Global Branded Generics Sales Quantity by Type (2019-2030)
5.2 Global Branded Generics Consumption Value by Type (2019-2030)
5.3 Global Branded Generics Average Price by Type (2019-2030)
6 麻豆原创 Segment by Application
6.1 Global Branded Generics Sales Quantity by Application (2019-2030)
6.2 Global Branded Generics Consumption Value by Application (2019-2030)
6.3 Global Branded Generics Average Price by Application (2019-2030)
7 North America
7.1 North America Branded Generics Sales Quantity by Type (2019-2030)
7.2 North America Branded Generics Sales Quantity by Application (2019-2030)
7.3 North America Branded Generics 麻豆原创 Size by Country
7.3.1 North America Branded Generics Sales Quantity by Country (2019-2030)
7.3.2 North America Branded Generics Consumption Value by Country (2019-2030)
7.3.3 United States 麻豆原创 Size and Forecast (2019-2030)
7.3.4 Canada 麻豆原创 Size and Forecast (2019-2030)
7.3.5 Mexico 麻豆原创 Size and Forecast (2019-2030)
8 Europe
8.1 Europe Branded Generics Sales Quantity by Type (2019-2030)
8.2 Europe Branded Generics Sales Quantity by Application (2019-2030)
8.3 Europe Branded Generics 麻豆原创 Size by Country
8.3.1 Europe Branded Generics Sales Quantity by Country (2019-2030)
8.3.2 Europe Branded Generics Consumption Value by Country (2019-2030)
8.3.3 Germany 麻豆原创 Size and Forecast (2019-2030)
8.3.4 France 麻豆原创 Size and Forecast (2019-2030)
8.3.5 United Kingdom 麻豆原创 Size and Forecast (2019-2030)
8.3.6 Russia 麻豆原创 Size and Forecast (2019-2030)
8.3.7 Italy 麻豆原创 Size and Forecast (2019-2030)
9 Asia-Pacific
9.1 Asia-Pacific Branded Generics Sales Quantity by Type (2019-2030)
9.2 Asia-Pacific Branded Generics Sales Quantity by Application (2019-2030)
9.3 Asia-Pacific Branded Generics 麻豆原创 Size by Region
9.3.1 Asia-Pacific Branded Generics Sales Quantity by Region (2019-2030)
9.3.2 Asia-Pacific Branded Generics Consumption Value by Region (2019-2030)
9.3.3 China 麻豆原创 Size and Forecast (2019-2030)
9.3.4 Japan 麻豆原创 Size and Forecast (2019-2030)
9.3.5 Korea 麻豆原创 Size and Forecast (2019-2030)
9.3.6 India 麻豆原创 Size and Forecast (2019-2030)
9.3.7 Southeast Asia 麻豆原创 Size and Forecast (2019-2030)
9.3.8 Australia 麻豆原创 Size and Forecast (2019-2030)
10 South America
10.1 South America Branded Generics Sales Quantity by Type (2019-2030)
10.2 South America Branded Generics Sales Quantity by Application (2019-2030)
10.3 South America Branded Generics 麻豆原创 Size by Country
10.3.1 South America Branded Generics Sales Quantity by Country (2019-2030)
10.3.2 South America Branded Generics Consumption Value by Country (2019-2030)
10.3.3 Brazil 麻豆原创 Size and Forecast (2019-2030)
10.3.4 Argentina 麻豆原创 Size and Forecast (2019-2030)
11 Middle East & Africa
11.1 Middle East & Africa Branded Generics Sales Quantity by Type (2019-2030)
11.2 Middle East & Africa Branded Generics Sales Quantity by Application (2019-2030)
11.3 Middle East & Africa Branded Generics 麻豆原创 Size by Country
11.3.1 Middle East & Africa Branded Generics Sales Quantity by Country (2019-2030)
11.3.2 Middle East & Africa Branded Generics Consumption Value by Country (2019-2030)
11.3.3 Turkey 麻豆原创 Size and Forecast (2019-2030)
11.3.4 Egypt 麻豆原创 Size and Forecast (2019-2030)
11.3.5 Saudi Arabia 麻豆原创 Size and Forecast (2019-2030)
11.3.6 South Africa 麻豆原创 Size and Forecast (2019-2030)
12 麻豆原创 Dynamics
12.1 Branded Generics 麻豆原创 Drivers
12.2 Branded Generics 麻豆原创 Restraints
12.3 Branded Generics Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
13 Raw Material and Industry Chain
13.1 Raw Material of Branded Generics and Key Manufacturers
13.2 Manufacturing Costs Percentage of Branded Generics
13.3 Branded Generics Production Process
13.4 Branded Generics Industrial Chain
14 Shipments by Distribution Channel
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Branded Generics Typical Distributors
14.3 Branded Generics Typical Customers
15 Research Findings and Conclusion
16 Appendix
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
Mylan NV
Novartis AG
Eva Pharmaceutical Industries
Pfizer
Sun Pharmaceutical Industries
Aspen Pharmacare Holding
Abbott Laboratories
Bausch Health
听
听
*If Applicable.
